Not applicableStudy completedNCT01762449What this trial is testingMorbidity and Mortality Follow Up for the Scleroderma Lung StudyWho this might be right forScleroderma Duke University 158
Not applicableNot Yet RecruitingNCT07305220What this trial is testingSafety Profile of Ultrasound-guided Transparietal Lung Biopsy in Patients With Diffuse Interstitial Lung DiseaseWho this might be right forInterstitial Lung Disease (ILD) University Hospital, Tours 15
Testing effectiveness (Phase 2)Study completedNCT03365791What this trial is testingPDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesWho this might be right forSmall Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more Novartis Pharmaceuticals 76
Testing effectiveness (Phase 2)Study completedNCT03543813What this trial is testingPROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCLWho this might be right forSolid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more CytomX Therapeutics 133
Early research (Phase 1)Study completedNCT02426229What this trial is testingSafety & Suitability of Dabigatran to Inhibit Thrombin in SclerodermaWho this might be right forSclerodermaInterstitial Lung Disease Medical University of South Carolina 15
Not applicableStudy completedNCT04383730What this trial is testingInhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)Who this might be right forCritically IllnessSedationInvasive Mechanical Ventilation+1 more University Hospital, Clermont-Ferrand 203
Not applicableNot Yet RecruitingNCT06980844What this trial is testingInterpretation of the Role of Eosinophils in Diffuse Interstitial PneumopathiesWho this might be right forInterstitial Lung Disease Hopital Foch 60
Not applicableStudy completedNCT04657484What this trial is testingComparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung DiseaseWho this might be right forPost COVID-19 Diffuse Lung Disease Post Graduate Institute of Medical Education and Research, Chandigarh 130
Not applicableStudy completedNCT00377949What this trial is testingMulti-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma PatientsWho this might be right forSystemic SclerosisSclerodermaPulmonary Hypertension+1 more Georgetown University 602
Not applicableStudy completedNCT05714787What this trial is testingOpportunistic Screening for Osteoporotic Vertebral Fractures in Patients With Diffuse Interstitial Lung DiseaseWho this might be right forOsteoporosisInterstitial Lung DiseaseVertebral Fracture Centre Hospitalier Universitaire de Nice 202
Early research (Phase 1)Study completedNCT01307267What this trial is testingPF-05082566 As A Single Agent And In Combination With RituximabWho this might be right forLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more Pfizer 190
Testing effectiveness (Phase 2)Study completedNCT00003269What this trial is testingAmifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid TumorsWho this might be right forBreast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more Scripps Health 20
Early research (Phase 1)Ended earlyNCT02376699What this trial is testingSafety Study of SEA-CD40 in Cancer PatientsWho this might be right forCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellHodgkin Disease+17 more Seagen Inc. 159
Not applicableActive Not RecruitingNCT06618924What this trial is testingDigital Modeling of Thoracic CT and Pulmonary FibrosisWho this might be right forInspiration Expiration Thoracic TDM Sequences of Patients With Diffuse Interstitial Lung Disease (DIP) Assistance Publique - Hôpitaux de Paris 300
Early research (Phase 1)Looking for participantsNCT05107674What this trial is testingNX-1607 in Adults With Advanced MalignanciesWho this might be right forOvarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more Nurix Therapeutics, Inc. 345
Early research (Phase 1)WithdrawnNCT02743546What this trial is testingStudy of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in LymphomaWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+1 more Janssen Research & Development, LLC
Early research (Phase 1)Ended earlyNCT04948554What this trial is testingMK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)Who this might be right forSystemic Sclerosis With and Without Interstitial Lung Disease Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 5
Early research (Phase 1)Active Not RecruitingNCT04491942What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Not applicableUnknownNCT04392726What this trial is testingUltra-Low Dose Computed Tomography For Diagnosis And Follow-Up Of Patients With Diffuse Parenchymal Lung Disease (DPLD)Who this might be right forDiffuse Parenchymal Lung Disease Sheba Medical Center 30